ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Pembrolizumab is on this study

  • The record lists it as a treatment, written “Pembrolizumab (neoadjuvant)”.
  • A model not recorded judged it given beside what the study tests. Nov 1, 2026, 6:35 AM UTC
  • The role rule says the same.
  • So Pembrolizumab's page lists this study under “Given beside what is tested”.
14 links0 made here, not in the record27 judgments2 judges (the rules as one: Rule based)3 record changes seen
Model not recordedRule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT06788912Pembrolizumab (MK-3475)Plus Investigational Agentsin Resectable Non-smallCell Lung Cancer (NSCLC)(MK-3475-01E/KEYMAKER-U01)Merck Sharp & Dohme LLCPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 28 · ClinicalTrials.gov record · Version of 2026-09-28Oct 13 · ClinicalTrials.gov record · Version of 2026-10-13Nov 13 · ClinicalTrials.gov record · Version of 2026-11-13Version of 2026-11-13CONDITIONSLung NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionParkinson Disease 4, Autoso…The registry's MeSH filing›Nov 14 · Rule based · MisfiledMisfiledDRUGSPembrolizumabEntry “Pembrolizumab (neoadjuvant)”, …›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackgroundCisplatinIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · BackgroundComparatorGemcitabineIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · BackgroundComparatorPemetrexedIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · BackgroundComparatorSacituzumab tirumotecanIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · BackgroundTestedAntihistaminesEntry “H1 receptor antagonist”, read …›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackgroundINT013197Entry “H2 receptor antagonist”, read …›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackgroundAcetaminophenEntry “Acetaminophen (or equivalent)”…›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackgroundDexamethasoneEntry “Dexamethasone (or equivalent)”…›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackgroundCarboplatinIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · BackgroundComparatorPaclitaxelIntervention entry›Nov 1 · A model not recorded · ComparatorNov 18 · Rule based · BackgroundComparatorSteroidsEntry “Steroid mouthwash (dexamethaso…›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
3 versions of the record seen on ClinicalTrials.gov, Sep 28–Nov 13 · changes seen, not judgments
Nov 1PembrolizumabA model not recordedBackgroundCurrent
Nov 1CisplatinA model not recordedComparatorCurrent
Nov 1GemcitabineA model not recordedComparatorCurrent
Nov 1PemetrexedA model not recordedComparatorCurrent
Nov 1Sacituzumab tirumotecanA model not recordedTestedCurrent
Nov 1AntihistaminesA model not recordedBackgroundCurrent
Nov 1INT013197A model not recordedBackgroundCurrent
Nov 1AcetaminophenA model not recordedBackgroundCurrent
Nov 1DexamethasoneA model not recordedBackgroundCurrent
Nov 1CarboplatinA model not recordedComparatorCurrent
Nov 1PaclitaxelA model not recordedComparatorCurrent
Nov 1SteroidsA model not recordedBackgroundCurrent
Nov 14Lung NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Parkinson Disease 4, Autosomal Dominant Lewy BodyRule based · condition-kind ruleMisfiledCurrent
Nov 18PembrolizumabRule based · role ruleBackgroundAgrees
Nov 18CisplatinRule based · role ruleBackgroundOverridden
Nov 18GemcitabineRule based · role ruleBackgroundOverridden
Nov 18PemetrexedRule based · role ruleBackgroundOverridden
Nov 18Sacituzumab tirumotecanRule based · role ruleBackgroundOverridden
Nov 18AntihistaminesRule based · role ruleBackgroundAgrees
Nov 18INT013197Rule based · role ruleBackgroundAgrees
Nov 18AcetaminophenRule based · role ruleBackgroundAgrees
Nov 18DexamethasoneRule based · role ruleBackgroundAgrees
Nov 18CarboplatinRule based · role ruleBackgroundOverridden
Nov 18PaclitaxelRule based · role ruleBackgroundOverridden
Nov 18SteroidsRule based · role ruleBackgroundAgrees
As of nowLung NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.